The OncoAlert Network 🚨

oncoalert.bsky.social

21 October 2026 14:30

Presenting OncoAlert Horizons | Focus: Breast Cancer Educational Series 🚨 WATCH HERE 👉 lnkd.in/gSCG_H_V In this session, we explore: Adjuvant Treatment Challenges in Early HR+/HER2− #BreastCancer Emerging Role of Next-Gen Oral SERDs Dr. @Prof. Dr. med. Sibylle Loibl🇩🇪and Dr. @Rupert Bartsch🇩🇪

EORTC Quality of Life Group (QLG)

qol.eortc.org

21 October 2026 13:35

📖 Yesterday afternoon at #ISOQOL, @msztankay.bsky.social presented the @eortc.org Patient-Reported Outcome Interpretation Guideline. The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our EORTC #QualityofLife Group website. #GivingVoice2Patients

The OncoAlert Network 🚨

oncoalert.bsky.social

04 September 2026 08:19

Presenting OncoAlert Horizons | Focus: Breast Cancer Educational Series 🚨In this session, we explore: Adjuvant Treatment Challenges in Early HR+/HER2− #BreastCancer Emerging Role of Next-Gen Oral SERDs WATCH 👉 youtu.be/tH0XDWL1RDY 🧑‍⚕️Faculty Dr. Prof. Dr. med. Sibylle Loibl🇩🇪and Dr. Rupert Bartsch🇩🇪

StockTitan

stocktitan.net

04 September 2026 08:14

#EXAS Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS https://www.stocktitan.net/news/EXAS/exact-sciences-the-nsabp-foundation-and-the-german-breast-group-13bzh3eed2ul.html

kleinleise

kleinleise.bsky.social

04 September 2026 08:13

„Warum möchten Sie den PD-L1-Inhibitor Atezolizumab?“ „Weil dieser alle Vokale enthält und dazu noch ein Bonus A.“ Komischerweise versteht hier keiner, dass das die perfekte Begründung ist.